Biomedicines (Jun 2021)

Proof-of-Concept for the Analgesic Effect and Thermoregulatory Safety of Orally Administered Multi-Target Compound SZV 1287 in Mice: A Novel Drug Candidate for Neuropathic Pain

  • Ádám István Horváth,
  • Nikolett Szentes,
  • Valéria Tékus,
  • Maja Payrits,
  • Éva Szőke,
  • Emőke Oláh,
  • András Garami,
  • Eszter Fliszár-Nyúl,
  • Miklós Poór,
  • Cecília Sár,
  • Tamás Kálai,
  • Szilárd Pál,
  • Krisztina Percze,
  • Éva Nagyné Scholz,
  • Tamás Mészáros,
  • Blanka Tóth,
  • Péter Mátyus,
  • Zsuzsanna Helyes

DOI
https://doi.org/10.3390/biomedicines9070749
Journal volume & issue
Vol. 9, no. 7
p. 749

Abstract

Read online

SZV 1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime) is a novel multi-target candidate under preclinical development for neuropathic pain. It inhibits amine oxidase copper containing 3, transient receptor potential ankyrin 1 and vanilloid 1 (TRPV1) receptors. Mainly under acidic conditions, it is transformed to the cyclooxygenase inhibitor oxaprozin, which is ineffective for neuropathy. Therefore, an enterosolvent capsule is suggested for oral formulation, which we investigated for nociception, basic kinetics, and thermoregulatory safety in mice. The antihyperalgesic effect of SZV 1287 (10, 20, 50, and 200 mg/kg, p.o.) was determined in partial sciatic nerve ligation-induced traumatic neuropathy by aesthesiometry, brain and plasma concentrations by HPLC, and deep body temperature by thermometry. Its effect on proton-induced TRPV1 activation involved in thermoregulation was assessed by microfluorimetry in cultured trigeminal neurons. The three higher SZV 1287 doses significantly, but not dose-dependently, reduced neuropathic hyperalgesia by 50% of its maximal effect. It was quickly absorbed; plasma concentration was stable for 2 h, and it entered into the brain. Although SZV 1287 significantly decreased the proton-induced TRPV1-mediated calcium-influx potentially leading to hyperthermia, it did not alter deep body temperature. Oral SZV 1287 inhibited neuropathic hyperalgesia and, despite TRPV1 antagonistic action and brain penetration, it did not influence thermoregulation, which makes it a promising analgesic candidate.

Keywords